CERIVASTATIN (CAS 145599-86-6) — formula C26H34FNO5, molecular weight 459.5.
| CAS Number | 145599-86-6 |
|---|---|
| Molecular Formula | C26H34FNO5 |
| Molecular Weight | 459.5 |
| LogP | 3.4 |
| Applications | Uses: ... Most effective and best-tolerated agents for treating dyslipidemia., Statins, Antihyperlipoproteinemic, ... agent that promotes a reduction of lipoprotein levels in the blood., Hydroxymethyglutaryl-CoA Reductase Inhibitors, Methods of Manufacturing: Prepared and claimed as methyl ester: R. Angerbauer et al., European patent office 325130, eidem, US patent 5006530, as (+)-form sodium salt: eidem, US patent (1989, 1991, 1993 all to Bayer)., Formulations, Preparations: Trade name (sodium salt): Baycol (Bayer, Smith Kline Beecham), Lipobay (Bayer), Zenas (Fournier) |
Documented applications: Uses: ... Most effective and best-tolerated agents for treating dyslipidemia., Statins, Antihyperlipoproteinemic, ... agent that promotes a reduction of lipoprotein levels in the blood., Hydroxymethyglutaryl-CoA Reductase Inhibitors, Methods of Manufacturing: Prepared and claimed as methyl ester: R. Angerbauer et al., European patent office 325130, eidem, US patent 5006530, as (+)-form sodium salt: eidem, US patent (1989, 1991, 1993 all to Bayer)., Formulations, Preparations: Trade name (sodium salt): Baycol (Bayer, Smith Kline Beecham), Lipobay (Bayer), Zenas (Fournier).
CERIVASTATIN is a chemical compound with CAS registry number 145599-86-6 and molecular formula C26H34FNO5 (molecular weight 459.5).
CAS number: 145599-86-6
Its molecular formula C26H34FNO5 comprises 26 C, 34 H, 1 F, 1 N, 5 O atoms.
Also known as: CERIVASTATIN · 西立伐他汀
The CAS registry number of CERIVASTATIN is 145599-86-6.
Molecular formula C26H34FNO5, molecular weight 459.5.
It is also registered under: CERIVASTATIN, 西立伐他汀.
Recorded applications: Uses: ... Most effective and best-tolerated agents for treating dyslipidemia., Statins, Antihyperlipoproteinemic, ... agent that promotes a reduction of lipoprotein levels in the blood., Hydroxymethyglutaryl-CoA Reductase Inhibitors, Methods of Manufacturing: Prepared and claimed as methyl ester: R. Angerbauer et al., European patent office 325130, eidem, US patent 5006530, as (+)-form sodium salt: eidem, US patent (1989, 1991, 1993 all to Bayer)., Formulations, Preparations: Trade name (sodium salt): Baycol (Bayer, Smith Kline Beecham), Lipobay (Bayer), Zenas (Fournier).
Independent reference data for CERIVASTATIN (CAS 145599-86-6), compiled from public chemistry databases.
| CAS Registry Number | 145599-86-6 |
|---|---|
| PubChem CID | 446156 |
| Molecular formula | C26H34FNO5 |
| IUPAC name | (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]-3,5-dihydroxyhept-6-enoic acid |
| UNII (FDA) | AM91H2KS67 |
| Molecular Weight | 459.5 |
|---|---|
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 459.24210135 |
| Monoisotopic Mass | 459.24210135 |
| Topological Polar Surface Area | 99.9 |
| Heavy Atom Count | 33 |
| LogP | 3.4 |
|---|---|
| LogP | 3.26 |
cerivastatin; 145599-86-6; Lipobay; Cerivastatina; AM91H2KS67; CHEBI:3558; (3R,5S,6E)-7-(4-(p-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoic acid; DTXSID9022786; cerivastatinum; RefChem:575215; DTXCID402786; C10AA06; cerivastatin acid; (3R,5S,E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoic acid; Cerivastatin (INN); CERIVASTATIN [INN]
CERIVASTATIN · CAS 145599-86-6 · C26H34FNO5. UNII AM91H2KS67. LogP: 3.4; LogP: 3.26.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 西立伐他汀